The company provides medicinal chemistry services powered by machine learning to design and synthesize molecules faster and at a lower cost. Using computational tools, PostEra optimizes the entire molecular design process, suggests new scaffolds, predicts the success of chemical reactions, and designs new synthetic routes to challenging molecules. PostEra has raised $26M from top investors, secured a $68M NIH partnership to prevent pandemics, and established a $260M partnership with Pfizer. The company also launched and helps lead the world's largest open-science initiative to find a COVID antiviral, COVID Moonshot.